Takeda faces thousands of Actos lawsuits from patients in the U.S.
Orlando, FL (PRWEB) May 17, 2012
The Actos Resource Center, a patient advocacy group, is alerting patients who suffered injury after taking the diabetes drug Actos of a recent change in court procedures which may streamline the process for them to file a claim for their loss.
The announcement comes nearly one year after the FDA first warned that Actos may be associated with a higher risk of bladder cancer last June 15, 2011. Since then, hundreds of people have contacted the Actos Resource Center with concerns over bladder cancer or other side effects.
According to a Bloomberg report, Takeda faces thousands of Actos lawsuits from patients in the U.S. In an article published March 13, 2012, the news agency predicted as many as 10,000 patients may eventually file an Actos bladder cancer lawsuit.
In December, a federal Judicial Panel on Multidistrict Litigation issued an order consolidating all lawsuits to a federal court in Louisiana. The case is known as In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).
United States District Judge Rebecca Doherty, who is overseeing the litigation, recently signed a direct-filing order for any new Actos lawsuits. This means that new victims that wish to file an Actos lawsuit in the MDL can do so directly, without first having to file a case in their local court and waiting for it to be transferred to the MDL.
The Actos Resource Center thinks this will help further streamline the litigation process for new victims and allow the potential cases to reach court or resolution even quicker. Currently, lawyers are helping those patients who took Actos and suffered bladder cancer, congestive failure or liver damage.
The MDL is also a more beneficial legal set up than an Actos class action lawsuit since it allows Actos victims to share evidence and resources, while still maintaining separate cases and individual awards.
According to The Canadian Press on April 19, 2012, Health Canada joined the United States, France, Germany and the European Medicines Agency in issuing warnings over the risk of bladder cancer from Actos.
The Actos Resource Center recommends that anyone diagnosed with bladder cancer who has legal questions talk with an expert drug injury attorney. The Actos Bladder Cancer Center only works with qualified Actos lawyers who are actively involved in this litigation and have handled thousands of cases.
For more information on the research, actos warnings, side effects and legal options relating to the drug Actos, or to speak with a lawyer, visit ActosCancer.com.